quinelorane has been researched along with naxagolide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Gust, CM | 1 |
| Ashmeade, T; Routledge, C; Taylor, S; Thorn, L | 1 |
| Goulet, M; Madras, BK | 1 |
3 other study(ies) available for quinelorane and naxagolide
| Article | Year |
|---|---|
Further characterization of tolerance to the corticosterone-elevating effect of pergolide in rats.
Topics: Animals; Corticosterone; Dopamine; Dopamine Agents; Ergolines; Male; Oxazines; Pergolide; Pharmaceutical Vehicles; Quinolines; Quinpirole; Rats; Rats, Inbred Strains | 1988 |
Elucidation of D3 receptor function in vivo: do D3 receptors mediate inhibition of dopamine neuronal activity?
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agonists; Ergolines; Male; Mice; Mice, Inbred Strains; Microdialysis; Neurons; Nucleus Accumbens; Oxazines; Quinolines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes | 1996 |
D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Benzazepines; Dopamine Agents; Dopamine Agonists; Dyskinesia, Drug-Induced; Female; Macaca fascicularis; Male; Motor Activity; Motor Skills; Oxazines; Parkinsonian Disorders; Phenanthridines; Quinolines; Receptors, Dopamine D1 | 2000 |